Overall EPIX gets a fundamental rating of 3 out of 10. We evaluated EPIX against 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for EPIX as it has an excellent financial health rating, but there are worries on the profitability. EPIX is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year EPIX has reported negative net income.
EPIX had a negative operating cash flow in the past year.
EPIX had negative earnings in each of the past 5 years.
In the past 5 years EPIX always reported negative operating cash flow.

1.2 Ratios

EPIX's Return On Assets of -22.73% is fine compared to the rest of the industry. EPIX outperforms 74.58% of its industry peers.
Looking at the Return On Equity, with a value of -23.07%, EPIX belongs to the top of the industry, outperforming 82.43% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-22.73%
ROE	-23.07%
ROIC	N/A

ROA(3y)-20.28%

ROA(5y)-21.7%

ROE(3y)-20.7%

ROE(5y)-22.14%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

EPIX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EPIX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, EPIX has more shares outstanding
EPIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

EPIX has an Altman-Z score of 0.99. This is a bad value and indicates that EPIX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.99, EPIX is in the better half of the industry, outperforming 61.50% of the companies in the same industry.
EPIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	0.99

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

EPIX has a Current Ratio of 69.06. This indicates that EPIX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 69.06, EPIX belongs to the best of the industry, outperforming 99.63% of the companies in the same industry.
A Quick Ratio of 69.06 indicates that EPIX has no problem at all paying its short term obligations.
EPIX has a better Quick ratio (69.06) than 99.63% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	69.06
Quick Ratio	69.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for EPIX have decreased by -6.67% in the last year.

EPS 1Y (TTM)-6.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%46.72%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 72.82% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-13.16%

EPS Next 2Y30.89%

EPS Next 3Y6.83%

EPS Next 5Y72.82%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

EPIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EPIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.